Soluble serum TRAIL levels have been found to be reduced in patients with acute coronary syndromes such as acute myocardial infarction [25] or unstable angina [26] compared to patients with stable CAD or healthy individuals, and inversely correlated with serum inflammatory markers such as C-reactive protein (CRP) [26]. This evidence concerns the gene CRP and coronary artery disorder.